Lombard Medical Inc.02.04.16
Irvine, Calif.-based Lombard Medical Inc. a medical device company focused on endovascular repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that the first commercial procedure using the revolutionary new Altura endovascular stent graft took place on Feb. 3, 2016, at University Hospital of South Manchester (UHSM) in the United Kingdom. The hospital is a major EVAR center within the National Health System servicing more than 180 EVAR patients annually.
“Endovascular aortic repair is the standard of care for patients requiring intervention for abdominal aortic aneurysm. The new Altura stent graft from Lombard significantly simplifies what can be a complex procedure while offering increased accuracy and control in stent graft deployment,” said Jonathan Ghosh, consultant vascular and endovascular surgeon at UHSM.
“We are now able to perform same day aortic aneurysm repair and the new Altura device should benefit both the patient and hospital with its 14F ultra low profile design, predictable procedure times and greatly reduced inventory requirements,” added Dr. Dare Sereki, consultant vascular interventional radiologist at UHSM.
“Our first commercial procedure is an important step in executing our Altura commercial strategy. We’d like to thank Mr. Ghosh, Dr. Sereki and University Hospital of South Manchester for this opportunity,” said Lombard CEO Simon Hubbert. “With the official launch last week at the Leipzig Interventional Course (LINC), we are looking to build on the physician interest and excitement surrounding Altura and expand our launch in the UK and German markets.”
“Endovascular aortic repair is the standard of care for patients requiring intervention for abdominal aortic aneurysm. The new Altura stent graft from Lombard significantly simplifies what can be a complex procedure while offering increased accuracy and control in stent graft deployment,” said Jonathan Ghosh, consultant vascular and endovascular surgeon at UHSM.
“We are now able to perform same day aortic aneurysm repair and the new Altura device should benefit both the patient and hospital with its 14F ultra low profile design, predictable procedure times and greatly reduced inventory requirements,” added Dr. Dare Sereki, consultant vascular interventional radiologist at UHSM.
“Our first commercial procedure is an important step in executing our Altura commercial strategy. We’d like to thank Mr. Ghosh, Dr. Sereki and University Hospital of South Manchester for this opportunity,” said Lombard CEO Simon Hubbert. “With the official launch last week at the Leipzig Interventional Course (LINC), we are looking to build on the physician interest and excitement surrounding Altura and expand our launch in the UK and German markets.”